IDEXX Laboratories Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 40.1% | 41.6% | 38.5% | 38.1% | 38.9% | 40.2% | 37.6% | 37.4% | 38.2% | 39.7% | 36.6% | 36.0% | 37.6% | |
| 59.9% | 58.4% | 61.5% | 61.9% | 61.1% | 59.8% | 62.4% | 62.6% | 61.8% | 60.3% | 63.4% | 64.0% | 62.4% | |
| 5.2% | 5.7% | 5.5% | 5.5% | 5.5% | 6.0% | 5.9% | 5.6% | 5.7% | 6.1% | 5.8% | 5.4% | 5.7% | |
| 9.7% | 9.7% | 9.5% | 15.7% | 9.4% | 10.6% | 9.2% | 8.9% | 9.6% | 10.0% | 10.4% | 9.6% | 9.9% | |
| 29.8% | 31.2% | 30.5% | 35.4% | 29.9% | 32.4% | 30.7% | 29.0% | 29.7% | 31.4% | 31.6% | 29.1% | 30.4% | |
| 30.1% | 27.2% | 31.0% | 26.3% | 31.2% | 27.4% | 31.7% | 33.6% | 32.1% | 28.9% | 31.8% | 35.0% | 32.0% | |
| 0.9% | 1.0% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 1.0% | 1.0% | 1.0% | 0.7% | 0.8% | 0.9% | |
| 29.3% | 26.6% | 30.6% | 25.8% | 30.6% | 26.9% | 31.1% | 32.7% | 31.2% | 28.1% | 31.2% | 34.3% | 31.3% | |
| 6.1% | 5.0% | 6.2% | 5.6% | 6.8% | 4.2% | 6.8% | 6.2% | 6.3% | 5.4% | 6.7% | 6.5% | 6.3% | |
| 23.2% | 21.6% | 24.4% | 20.3% | 23.9% | 22.7% | 24.3% | 26.5% | 24.8% | 22.8% | 24.4% | 27.8% | 25.0% | |
| 33.4% | 30.9% | 34.7% | 30.0% | 35.1% | 31.3% | 35.2% | 36.9% | 35.5% | 32.7% | 35.1% | 38.5% | 35.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.